Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nieuweboer AJ"'
Autor:
Nieuweboer AJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., de Graan AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands., Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van Soest RJ; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van Alphen RJ; Department of Internal Medicine, TweeSteden Ziekenhuis, Tilburg, the Netherlands., Bergman AM; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Beeker A; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, the Netherlands., van Halteren H; Department of Internal Medicine, Admiraal de Ruyter Ziekenhuis, Goes/Vlissingen, the Netherlands., Ten Tije AJ; Department of Internal Medicine, Amphia Ziekenhuis, Breda, the Netherlands., Zuetenhorst H; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands., van der Meer N; Clinical Trial Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Chitu D; Clinical Trial Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. a.mathijssen@erasmusmc.nl.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Apr 01; Vol. 23 (7), pp. 1679-1683. Date of Electronic Publication: 2016 Oct 04.
Autor:
Nieuweboer AJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., de Graan AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Elbouazzaoui S; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Eskens FA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Hamberg P; Department of Internal Medicine, St. Franciscus Gasthuis, Rotterdam, The Netherlands., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Sparreboom A; Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN, USA., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van Schaik RH; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
The pharmacogenomics journal [Pharmacogenomics J] 2016 Nov; Vol. 16 (6), pp. 519-524. Date of Electronic Publication: 2015 Sep 08.
Autor:
Onstenk W; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands. Electronic address: w.onstenk@erasmusmc.nl., Sieuwerts AM; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., Kraan J; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., Van M; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., Nieuweboer AJ; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., Mathijssen RH; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., Hamberg P; Sint Franciscus Gasthuis, Department of Internal Medicine, Rotterdam, The Netherlands., Meulenbeld HJ; Gelre Ziekenhuizen, Department of Internal Medicine, Zutphen, The Netherlands., De Laere B; GZA Hospitals Saint Augustinus, Wilrijk, Belgium; Center for Oncological Research, University of Antwerp, Antwerp, Belgium., Dirix LY; GZA Hospitals Saint Augustinus, Wilrijk, Belgium; Center for Oncological Research, University of Antwerp, Antwerp, Belgium., van Soest RJ; Erasmus MC, Department of Urology, Rotterdam, The Netherlands., Lolkema MP; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., Martens JW; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., van Weerden WM; Erasmus MC, Department of Urology, Rotterdam, The Netherlands., Jenster GW; Erasmus MC, Department of Urology, Rotterdam, The Netherlands., Foekens JA; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., de Wit R; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands., Sleijfer S; Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Department of Medical Oncology, Rotterdam, The Netherlands.
Publikováno v:
European urology [Eur Urol] 2015 Dec; Vol. 68 (6), pp. 939-45. Date of Electronic Publication: 2015 Jul 15.
Autor:
van Soest RJ; Department of Urology, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands. Electronic address: r.vansoest@erasmusmc.nl., Nieuweboer AJ; Department of Medical Oncology, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands., de Morrée ES; Department of Urology, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands., Chitu D; Department of Biostatistics, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands., Bergman AM; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Goey SH; Department of Internal Medicine, Tweesteden Hospital, Tilburg, The Netherlands., Bos MM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands., van der Meer N; Department of Clinical Trial Center, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands., Hamberg P; Department of Internal Medicine, St Franciscus Gasthuis and Prostate Cancer Center, Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus University Medical Center and Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2015 Nov; Vol. 51 (17), pp. 2562-9. Date of Electronic Publication: 2015 Aug 13.
Autor:
Nieuweboer AJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: a.nieuweboer@erasmusmc.nl., de Morrée ES; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., de Graan AJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sparreboom A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN, United States., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Cancer treatment reviews [Cancer Treat Rev] 2015 Jul; Vol. 41 (7), pp. 605-13. Date of Electronic Publication: 2015 May 07.
Autor:
Kraff S; Institute of Pharmacy, Clinical Pharmacy, University of Bonn, An der Immenburg 4, 53121, Bonn, Germany., Nieuweboer AJ, Mathijssen RH, Baty F, de Graan AJ, van Schaik RH, Jaehde U, Joerger M
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2015 May; Vol. 75 (5), pp. 975-83. Date of Electronic Publication: 2015 Mar 12.
Autor:
Nieuweboer AJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands., de Graan AJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands., Elbouazzaoui S; Department of Clinical Chemistry, Erasmus University Medical Center, s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands., de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands., Mathijssen RH; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands., van Schaik RH; Department of Clinical Chemistry, Erasmus University Medical Center, s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.
Publikováno v:
Pharmacogenomics [Pharmacogenomics] 2015; Vol. 16 (11), pp. 1231-41. Date of Electronic Publication: 2015 Aug 12.
Autor:
Nieuweboer AJ; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri., Hu S; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri., Gui C; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri., Hagenbuch B; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri., Ghobadi Moghaddam-Helmantel IM; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri., Gibson AA; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri., de Bruijn P; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri., Mathijssen RH; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri a.mathijssen@erasmusmc.nl., Sparreboom A; Authors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, MissouriAuthors' Affiliations: Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri.
Publikováno v:
Cancer research [Cancer Res] 2014 Jun 01; Vol. 74 (11), pp. 3137-45. Date of Electronic Publication: 2014 Apr 22.
Autor:
de Graan AJ; Authors' Affiliations: Departments of Medical Oncology, Clinical Chemistry, and Trials and Statistics, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden., Elens L, Smid M, Martens JW, Sparreboom A, Nieuweboer AJ, Friberg LE, Elbouazzaoui S, Wiemer EA, van der Holt B, Verweij J, van Schaik RH, Mathijssen RH
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2013 Sep 15; Vol. 19 (18), pp. 5210-7. Date of Electronic Publication: 2013 Aug 05.
Autor:
Zuiverloon TC; Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands., Beukers W, van der Keur KA, Nieuweboer AJ, Reinert T, Dyrskjot L, Orntoft TF, Zwarthoff EC
Publikováno v:
The Journal of urology [J Urol] 2013 May; Vol. 189 (5), pp. 1945-51. Date of Electronic Publication: 2012 Nov 28.